Sysmex Corp
0YX
Company Profile
Business description
Sysmex Corp manufactures and sells laboratory testing equipment and reagents. It conducts product development, manufacturing, sales, and service activities in domestic markets, while certain products are also developed, manufactured, and sold through its subsidiaries. The company operates through five reportable segments based on headquarters: Head Office Management, Americas Headquarters, EMEA Headquarters, China Headquarters, and AP Headquarters.
Contact
1-5-1 Wakihama Kaigan-dori
Chuo-ku, Hyogo Prefecture
Kobe651-0073
JPNT: +81 782650500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2027
Employees
11,369
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.90 | 43.80 | 0.48% |
| CAC 40 | 8,203.24 | 60.63 | -0.73% |
| DAX 40 | 23,712.39 | 368.24 | -1.53% |
| Dow JONES (US) | 47,867.32 | 42.60 | -0.09% |
| FTSE 100 | 10,586.43 | 22.45 | -0.21% |
| HKSE | 25,752.40 | 140.62 | -0.54% |
| NASDAQ | 22,571.03 | 63.97 | -0.28% |
| Nikkei 225 | 55,895.32 | 413.10 | -0.73% |
| NZX 50 Index | 13,273.81 | 19.87 | 0.15% |
| S&P 500 | 6,774.43 | 8.38 | -0.12% |
| S&P/ASX 200 | 8,973.20 | 57.80 | 0.65% |
| SSE Composite Index | 3,966.17 | 28.83 | -0.72% |